Dipeptidyl peptidase IV and related molecules in health and disease
Submission Deadline: 31 Dec 2019
Guest Editors
Ph.D., Dana-Farber Cancer Institute, Medical Oncology, JF517, 450 Brookline Avenue, Boston MA 02215
Interests: 70 publications, 7 grants, Editor of Frontiers in Bioscience
M.D., Ph.D., Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology of the First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic
Interests: >50 publications, grants, Editor of Frontiers in Bioscience
Keywords
- Blood and Bone Marrow
- Cancer
- Cardiovascular System
- Cell Biology
- Development
- Endocrine System
- Genes and Genetics
- Immune System
- Inflammatory Responses
- Nervous System
- Nutrition
- Molecular Biology
- Signaling
- Skin and Integument
- Therapeutics
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (24)
Anti-diabetic treatment leads to changes in gut microbiome
Front. Biosci. (Landmark Ed) 2019, 24(4), 688–699; https://doi.org/10.2741/4743
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond
Front. Biosci. (Landmark Ed) 2019, 24(4), 648–687; https://doi.org/10.2741/4742
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Fibroblast activation protein in liver fibrosis
Fibroblast activation protein in liver fibrosis
Front. Biosci. (Landmark Ed) 2019, 24(1), 1–17; https://doi.org/10.2741/4706
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Targeting fibroblast activation protein in cancer – Prospects and caveats
Targeting fibroblast activation protein in cancer – Prospects and caveats
Front. Biosci. (Landmark Ed) 2018, 23(10), 1933–1968; https://doi.org/10.2741/4682
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target
A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target
Front. Biosci. (Landmark Ed) 2018, 23(9), 1754–1779; https://doi.org/10.2741/4671
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Dipeptidyl peptidase 8 and 9 - guilty by association?
Dipeptidyl peptidase 8 and 9 - guilty by association?
Front. Biosci. (Landmark Ed) 2009, 14(10), 3619–3633; https://doi.org/10.2741/3476
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice
Front. Biosci. 2008, 13(18), 6850–6858; https://doi.org/10.2741/3193
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors
Front. Biosci. 2008, 13(10), 3699–3713; https://doi.org/10.2741/2960
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes
Front. Biosci. 2008, 13(10), 3648–3660; https://doi.org/10.2741/2956
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Purification and characterization of a dipeptidyl peptidase 9-like enzyme from bovine testes
Purification and characterization of a dipeptidyl peptidase 9-like enzyme from bovine testes
Front. Biosci. 2008, 13(9), 3558–3568; https://doi.org/10.2741/2949
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function
Front. Biosci. 2008, 13(9), 3194–3201; https://doi.org/10.2741/2920
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Fibroblast activation protein and chronic liver disease
Fibroblast activation protein and chronic liver disease
Front. Biosci. 2008, 13(8), 3168–3180; https://doi.org/10.2741/2918
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation
Front. Biosci. 2008, 13(7), 2435–2443; https://doi.org/10.2741/2856
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases
Front. Biosci. 2008, 13(6), 2364–2375; https://doi.org/10.2741/2850
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis
Front. Biosci. 2008, 13(6), 2356–2363; https://doi.org/10.2741/2849
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis
Front. Biosci. 2008, 13(6), 2335–2355; https://doi.org/10.2741/2848
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors - good or evil?
Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors - good or evil?
Front. Biosci. 2008, 13(6), 2319–2326; https://doi.org/10.2741/2846
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Role of CD26/dipeptidyl peptidase IV in human T cell activation and function
Front. Biosci. 2008, 13(6), 2299–2310; https://doi.org/10.2741/2844
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
Front. Biosci. 2008, 13(5), 1795–1805; https://doi.org/10.2741/2800
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes
Front. Biosci. 2008, 13(5), 1780–1794; https://doi.org/10.2741/2799
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26
Front. Biosci. 2008, 13(5), 1774–1779; https://doi.org/10.2741/2798
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Dipeptidyl peptidase IV inhibitors and diabetes therapy
Front. Biosci. 2008, 13(5), 1753–1773; https://doi.org/10.2741/2797
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
The role of CD26/dipeptidyl peptidase IV in cancer
Front. Biosci. 2008, 13(5), 1634–1645; https://doi.org/10.2741/2787
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)
Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor
Front. Biosci. 2008, 13(5), 1610–1618; https://doi.org/10.2741/2785
(This article belongs to the Special Issue Dipeptidyl peptidase IV and related molecules in health and disease)